Purpose: To evaluate 8-year results of photorefractive keratectomy (PRK) for myopia in terms of safety, efficacy, stability, and late complications.
D
uring recent 25 years, corneal excimer laser has evolved from a series of experiments in animals to millions of clinical procedures. In the early days, there was only photorefractive keratectomy (PRK). [1] [2] [3] [4] [5] [6] [7] This technique saw the emergence of a number of commercial laser systems and treatment algorithms, together with a progressive increase in the size of ablation zones. [8] [9] [10] [11] [12] [13] In 1991, a major change was made in the field of refractive surgery with the advent of laser in situ keratomileusis (LASIK). 14, 15 Although the risks associated with LASIK were considered to be low, intraoperative and postoperative flap-related complications are sight threatening and have resulted in permanent loss of best spectaclecorrected visual acuity (BSCVA). [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] Although PRK has given its popularity to LASIK, PRK remains an important procedure where LASIK is not possible or not favored. In addition, PRK is now gaining a renewed interest because of the potential for wave front-guided custom laser procedure because such treatment is not buried under a corneal flap. 29 The short-term problems associated with PRK were reported pain in the first 24 hours; a delay in visual recovery lasting 3-5 days during epithelial healing; and a transient loss of corneal transparency, termed ''haze,'' for a period of weeks to months after surgery. 2, 7, 13 Myopic postoperative regression and corneal haze have been reported to be the most common complications of PRK. [30] [31] [32] [33] For any corneal refractive surgical procedure, it is essential to monitor long-term stability and efficacy. [34] [35] [36] [37] [38] [39] Few studies have followed PRK cases for more than 6 years. [40] [41] [42] [43] [44] [45] Moreover, except the study of Alió et al, 44, 45 none of previous long-term studies on PRK included the data of retreatment in the analysis of final results. Given the limited availability of such data in the literature, we present in this study the results of an 8-year follow-up of a nonconsecutive series of myopic eyes undergoing PRK.
MATERIALS AND METHODS

Patients
Between April 1997 and February 1998, 371 myopic eyes (203 patients) were treated with single-step PRK, in Basir Eye Center, Tehran, Iran. One hundred ninety-four eyes (107 patients, 69 males and 38 females) (52.3%) of the original cohort study returned for follow-up $8 years after the initial procedure. Patients were divided into 3 groups according to preoperative refraction: low myopia [#26.00 diopters (D)], moderate myopia (26.10 to 210.00 D), and high myopia (. 210.00 D). Astigmatism (0 to 20.50 D) was not corrected.
Surgical Procedure
Inclusion criteria for surgery were minimum age of 18 years, BSCVA of at least 20/40 or better, and stable refraction for at least 1 year before surgery. The exclusion criteria for surgery were patients who had undergone previous corneal surgery, pupil size $6 mm, keratoconus, preoperative corneal opacity, any corneal dystrophy, severe pterygium, pellucid marginal degeneration, retinal disorders (such as lattice degeneration, retinal hole or tear, and congenital retinal disorders), collagen vascular disorders, diabetes mellitus, glaucoma, cataract, history of ocular surgery, pregnancy, breastfeeding, and systemic corticosteroid therapy. All patients received comprehensive information about the surgery, its outcomes, and complications before, during, and after surgery. We asked all the participants to sign an informed consent before treatment and for further follow-up examinations.
All patients underwent single-step PRK using NIDEK EC-5000 (model CX II; NIDEK, Gamagori, Japan). One surgeon (A.S.) performed all procedures. Before ablation with excimer laser, pilocarpine 2% and tetracaine hydrochloride 0.5% eyedrops were applied for pupil constriction and topical anesthesia, respectively. After marking 7 mm on cornea, corneal epithelium was mechanically removed by spatula. Ablation depth was assigned according to ablation zone, diameter, and degree of refractive error. Based on patients' age and preoperative refractive error, ablation zone was from 5.5 to 6 mm. After surgery, a pressure patch was placed for 3-5 days. All patients received chloramphenicol 0.2% eyedrops during first week after surgery. After completion of reepithelialization of cornea, betamethasone 0.1% eyedrops was prescribed 4 times a day, at the first month; then it was changed to fluorometholone 0.1% eyedrops 4 times a day in the second month and tapered over the third month. Mitomycin-C was not part of standard treatment when surgeries were performed.
Preoperative and Postoperative Examinations
All patients underwent thorough ophthalmologic examinations before surgery, including measurement of uncorrected visual acuity (UCVA), BSCVA, subjective and cycloplegic refraction, ultrasonic pachymetry (NIDEK UP 1000; NIDEK Company, Gamagori, Japan), computerized corneal topography (EyeSys Vista, Houston, TX), slit-lamp examination, tonometry, and fundus examination. The patients were asked to return for follow-up at 1 and 7 days; 3 weeks; and 1, 3, and 6 months then annually after the initial procedure, either spontaneously or after telephone calls (particularly after first year). One surgeon performed these examinations, which included measurement of visual acuities (UCVA and BSCVA), subjective refraction, and slit-lamp examination. If there was any visual impairment, cycloplegic refraction, corneal pachymetry, and topography were performed. We scaled corneal haze according to the study of Fantes et al 46 after surgery; grade 4 indicates that the cornea is completely opaque.
Retreatments
The criteria for retreatment were at the patient's and surgeon's discretion but usually determined by the patient's desire for improved UCVA. 47 Retreatment was allowed if the UCVA was worse than 20/25 or the residual refractive error was 0.75 D or more and the UCVA and refraction were stable. Stability was defined when there was a difference in the refraction less than 0.5 D, taking at two 1-month intervals. The retreatment was done 6 months or more after the primary PRK.
Pre-retreatment assessment included a complete ophthalmic examination, including manifest refraction, slit-lamp examination, recording of UCVA and BSCVA, haze evaluation, applanation tonometry, retinoscopy with cycloplegic refraction, dilated fundus examination, and video-assisted corneal topography.
All retreatments were performed by the same surgeon (A.S.) using the same NIDEK EC-5000 at the same laser center (Basir Eye Center, Tehran, Iran). The postoperative protocol was the same as that for primary surgery. Our results included the retreatment data.
Statistical Analysis
Visual acuity measurements were performed using Snellen acuities and analyzed using logMAR equivalents. Statistical analysis was performed using the SPSS statistics software package, SPSS 13.0 for Windows (SPSS, Inc, Chicago, IL). The normal probability plots confirmed normality of the data in each group. To compare preoperative and postoperative measures, nonparametric Wilcoxon test and repeated measure analysis of variance were used. A P value less than 0.05 was considered significant.
RESULTS
Accountability
During 8 years, 173 eyes (46.63%) from the original cohort study were lost to follow-up. They did not return for follow-up examinations for reasons unrelated to laser treatment, including noncompliance with the visit schedule and moving out of the city. All data from these eyes were omitted from the analysis. Table 1 shows comparison of patients' demographics in 371 eyes of 203 patients who underwent PRK for myopia and lost to follow-up group. Mean spherical equivalent of lost to follow-up group at the last visit was 20.62 6 0.8 D (0.25 6 21.25 D). Four eyes (1.07%) were excluded from the analysis (not included in the 371 total eyes) because of incorrect data entry of refractive information into the laser machine, which was considered a protocol deviation. This study also includes the data of 16 retreated eyes (4.3%) for which their retreatment procedure was performed during the first 2 years after initial surgery. Eight-year followup data were available for 194 eyes, representing a 52.3% accountability of all subjects eligible for the visits.
Refraction
The mean age of 69 males and 38 females, who participated in annual examinations, was 33.4 6 8.1 years (age range, 20-58 years) at the time of surgery ( Table 2 shows residual refractive error 8 years after PRK in 194 eyes that were grouped according to preoperative refraction. Changes in mean spherical refraction over 8 years, according to the preoperative myopic groups, are presented in Figure 1 . Most refractive regression occurred during the first 18 months. It stabilized in all myopic groups within 2 years. Changes in refraction during the first 18 months correlated significantly to preoperative spherical refraction (r = 0.31, P = 0.007, all myopic groups). Refraction changes between 3 and 8 years correlated neither to preoperative spherical refraction nor to patients' age. Moreover, changes in refraction between 3 and 8 years did not correlate to the first postoperative year.
Visual Acuity
Comparison of UCVA and BSCVA in 3 myopic groups at 1, 2, and 8 years after PRK is shown in Table 3 Figure 2 shows the percentage of eyes that lost or gained Snellen lines of visual acuity at the last follow-up.
Complications
Twenty-two eyes (11.34%) experienced corneal haze, which were categorized based on severity and myopic groups and shown in Table 4 . Residual corneal haze was less frequent in low myopic group (2 eyes; 1.78%), in comparison with moderate group (7 eyes; 19.44%) and high group (13 eyes; 28.26%). From all hazed eyes, 2 eyes (9.09%) of 2 patients lost 9 lines, 2 eyes (9.09%) of 2 patients lost 4 lines, and 4 eyes (18.18%) of 3 patients lost 2 lines of BSCVA during first 18 months after surgery. For all cases with corneal haze, betamethasone 0.1% was prescribed 4 times a day, for the first month, with monitoring intraocular pressure; then it was changed to fluorometholone 0.2% 4 times a day for another 
Case 2
A 34-year-old man had a preoperative refraction of 29.00 and 27.5 D with a BSCVA of 20/20 in the right and left eyes, respectively. He had PRK in both eyes in 1997. Three months after surgery, the patient reported a progressive Changes in refraction between 1 and 12 months after PRK correlated significantly to both 6-and 12-month haze grades (r = 20.75 and r = 20.69, respectively, P , 0.001, all myopic groups). However, changes in refraction between 2 and 8 years did not correlate to the corneal haze, which was observed during the first 2 years after surgery (P . 0.05).
Overcorrection occurred in 40 eyes (20.61%) ( Table 5 ). During the first 2 years, 37 eyes (92.5% of all overcorrected eyes) regressed to emmetropia. Overcorrection regressed to 0.5 D in other 3 eyes (7.5%) at the final follow-up. Postoperative complications are presented in Table 5 . Regression was observed in 31 eyes (15.97%), whereas undercorrection and diplopia occurred in 7 eyes (3.60%) and 1 eye (0.51%), respectively.
Retreatment
Sixteen eyes (4.31%; 5 males and 6 females) of 371 eyes underwent retreatment. These eyes belonged to 2 patients (2 eyes; 12.5%) in low, 4 patients (6 eyes; 37.5%) in moderate, and 5 patients (8 eyes; 50%) in high myopic groups. The primary indication for retreatment was significant regression (11 eyes; 68.75%) relative to the original myopia, which led to the patients' requests for treatment of their residual myopia, then undercorrection (5 eyes; 31.25%). Retreated eyes had a UCVA of 20/40 or better before retreatment. All retreated eyes underwent only 1 retreatment after 6 months of follow-up. Three months after retreatment, 9 eyes (56.25%) achieved a UCVA of 20/20 or better and 14 eyes (87.5 %) achieved a UCVA of 20/32 or better. Twelve eyes (75%) and 16 eyes (100%) had a manifest refraction spherical equivalent within 60.50 and 61.00 D of the intended correction 3 months after retreatment. After 5 years, 1 eye belonging to 1 patient from high myopic group did not return for other follow-up examinations. Therefore, we removed his data from the analysis of final results. At the final follow-up, he had 20.5 D residual refraction error and UCVA of 20/25 in both eyes.
DISCUSSION
In this study, we conducted an 8-year follow-up study to evaluate safety, efficacy, and stability of PRK for myopia. At the final follow-up, mean residual refraction was excellent in low, good in medium, and satisfactory in high myopic groups. Regression stabilized within 2 years, and there was correlation between preoperative spherical equivalent and first 18-month regression. Majority of postoperative corneal haze resolved during 2 years.
Alió et al, 44, 45 using VISX 20/20 excimer laser, conducted 10-year, retrospective, interventional case series follow-up studies to evaluate outcome of PRK with a 5.5-to 6-mm ablation zone in 2 groups of eyes with less and more than 26 D myopia (225 and 267 eyes, respectively). They included the data of retreatment in final analysis. At 10 years, 169 (75%) of 225 low myopic eyes and 156 (58%) of 267 high myopic eyes were within 61.00 D of emmetropia. Ninety-five (42%) and 124 (46.4%) eyes underwent retreatment in low and high myopic groups, respectively. The mean SE slightly decreased (myopic regression) over 10 years in both groups. Corneal haze score gradually decreased in both groups at 10 years. They finally concluded that PRK for both myopic groups is a safe and effective procedure in the long term. O'Connor et al 43 evaluated 12-year outcome of PRK, using the Summit Technology UV 200 excimer laser with a 5-mm ablation zone in 58 myopic eyes. Change in manifest refraction at 2 years was 20.27 6 0.55 D and at 12 years was 20.58 6 0.72 D, respectively. The level of preoperative BSCVA was maintained or improved in 87.9% of eyes. At 12 years, 62.1% were within 60.50 D of emmetropia and trace haze was noted in 17.2% of eyes. Rajan et al, 42 using Summit Technology UV 200 excimer laser, conducted 12-year cohort follow-up study to evaluate outcome of PRK in 68 myopic eyes with a 4-mm ablation zone. Patients were allocated to 1 of 6 treatment groups based on their preoperative refraction. Each group received one of the following spherical corrections: 22, 23, 24, 25, 26, or 27 D. Patients in each group received an identical treatment, and therefore, in their study, emmetropia was not the primary aim. The postoperative refraction remained stable at 12 years, with no significant change in mean spherical equivalent refraction between 1, 6, and 12 years. At the end of their study, 75%, 65%, 57%, 50%, 25%, and 22% of patients who received 22, 23, 24, 25, 26 , and 27 D correction, respectively, were within 61 D of intended correction. They concluded that refractive stability achieved at 1 year was maintained up to 12 years with no evidence of hyperopic shift, diurnal fluctuation, or late regression in the long-term follow-up after PRK. Corneal haze decreased with time, with complete recovery of BSCVA. Summary of previous studies, which evaluated the long-term follow-up of PRK for correction of myopia, was presented in Table 6 .
In our study, mean of PRK-induced refractive changes, in each myopic group, stabilized within 2 years. Most refractive regression occurred during the first 18 months. Changes in refraction during the first 18 months correlated with [39] [40] [41] [42] [43] [44] [45] Based on different studies, changes in refraction correlated significantly to preoperative refraction during the first postoperative year. [39] [40] [41] [42] [43] [44] [45] We had a little regression within 8 years after surgery, but as Pietila et al 41 noted, it may be a result of surgery or perhaps caused by a natural age-related refractive change. In our study, there was no significant evidence of late regression or progressive hyperopic shift. Other studies support our findings. [39] [40] [41] [42] [43] [44] [45] In our study, corneal haze occurred in 11.34% of eyes but it cleared in 68.2% of affected eyes within 2 years. Corneal haze cleared within 12 months after surgery in low myopic group and 2 years in moderate and high myopic groups. Other long-term studies [39] [40] [41] [42] [43] [44] [45] pointed out that residual corneal haze occurred in 4%-54.2% of operated eyes. It decreases with time with complete recovery of BSCVA. In our study, corneal haze caused loss of 2 lines of BSCVA in just 1 eye. There was no evidence of progressive time-dependent hyperopic shift, late regression, or late-onset corneal haze after PRK. As Table 6 shows, larger optical zones decreased side effects like corneal haze and losing of lines of BSCVA. [40] [41] [42] [43] [44] [45] Previous studies with shorter follow-up found a retreatment rate between 20%-26.8% and 23%-50% after PRK for low and moderate myopia, respectively. 33, 35, 49, 50 In our study, 16 eyes (4.31%) underwent retreatment with higher rate in high myopic group. At the final follow-up, they had excellent outcome. Except the study of Alió et al, 44, 45 none of previous long-term studies included the data of retreatment in the analysis of final results. They reoperated 95 (42%) and 124 (46.4%) eyes in low and high myopic groups, respectively. Their main indication for retreatment was undercorrection (64% and 61% in low and high retreated myopic groups, respectively), then regression (21% and 30% in low and high retreated myopic groups, respectively). They had more than 1 retreatment in 22% and 28% of retreated cases in low and high myopic groups. ''Retreatment frequency'' or incidence varies from center to center and depends on a number of factors, including the upper limit of myopia treated, the type of laser, the maximum ablation zone diameter used, and the threshold of both patient and surgeon in requesting and performing a PRK retreatment. 47 In contrast to Alió's studies, our main indication for retreatment was regression. It might be explainable based on differences between the types of used lasers because we had higher rate of overcorrection.
According to this study, postoperative refraction of majority of eyes remains stable after second year up to eighth year and most cases of corneal haze clear within 2 years after surgery. We found that residual refraction in myopic groups, which were treated by single-step PRK with 5.5-to 6-mm ablation zone, maintained for up to 8 years. Corneal haze was transient and resolved by the second year in a majority of patients. There were no sight-threatening complications in our study. Based on our 8-year follow-up study, PRK is a safe, efficient, and stable surgical procedure for correction of myopia, and if patients obtain a good result with the initial treatment, then their results are relatively stable over time. 
